Find out more about Adam Parslow's experience
Adam Parslow's highlights
Adam Parslow's selected work
Preclinical evaluation of a mTOR specific PET ligand in a RAD001 sensitive/resistant breas..
Confocal Microscopy Reveals Cell Surface Receptor Aggregation Through Image Correlation Sp..
DEVELOPMENT OF MTORC1 SPECIFIC AGENTS FOR EVALUATION OF HER2 TARGETED THERAPY USING PET
HARNESSING ANALOGUES OF THE ONCRASIN-1 FOR RADIOTRACER IMAGING OF TARGETED THERAPY RESISTA..
Displaying the 7 most recent scholarly works by Adam Parslow.
Synthesis and validation of [18F]mBPET-1, a fluorine-18 labelled mTOR inhibitor derivative based on a benzofuran backbone.
Christian W Wichmann, Yit Wooi Goh, Adam C Parslow, Angela Rigopoulos, Nancy Guo, Andrew M Scott, Uwe Ackermann, Jonathan M White
Journal article | 2020 | EJNMMI Radiopharmacy and Chemistry
BACKGROUND: Targeted therapy of HER2 positive breast cancer has led to clinical success in some cases with primary and secondary r..
Baker Department Of Cardiometabolic Health